Katharina Kiss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Grants Break Through Device Designation for TricValve Transcatheter Bicaval Valves System
Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA)
The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to P+F Products + Features GmbH TricValve Transcatheter Bicval Valves System. The system uses two self-expanding valves in the vena cava for the treatment of patients with hemodynamically relevant tricuspid insufficiency without the need to touch the native tricuspid valve.
January 6, 2021 The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to P+F Products + Features GmbH TricValve Transcatheter Bicval Valves System.   ....

Gmbh Tricvalve Transcatheter Bicval , Samir Kapadia , Department Of Cardiovascular Medicine , Drug Administration , Cardiovascular Medicine , Rishi Puri , Katharina Kiss , சமீர் கபாடியா , துறை ஆஃப் இருதய மருந்து , இருதய மருந்து , ரிஷி பூரி , காதரின முத்தம் ,